Sharon Stevenson is the Co-Founder and Managing Director of Okapi Venture Capital. See sector focus and contact routes.
Sharon Stevenson is the Co-Founder and Managing Director of Okapi Venture Capital, where she leads the firm’s life science investments and holds over 14 years of venture capital experience focused on early-stage healthcare. She co-founded Okapi in 2005, and the firm targets seed and early-stage companies in information technology and life sciences, primarily within Southern California, especially Orange County. Stevenson’s typical investment range is $500,000 to $2.0 million, with a sweet spot at $500,000, and she has recorded 15 investments, often acting as a lead investor in Okapi’s first two funds. Notable portfolio companies she backed include Helixis (acquired by Illumina), Focal Therapeutics (acquired by HOLX), WellTok (acquired by Virgin Pulse), and Obalon Therapeutics (merged with Resound Life Sciences). She serves as a Director on the boards of WiserCare and BioTrace and is a Board Observer at OrthAlign, reflecting deep operational involvement. Stevenson holds a DVM, PhD in Comparative Pathology, and an MBA, combining scientific expertise with business strategy to inform her early-stage life science thesis.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Laguna Beach.
Investors like Sharon Stevenson · Full investor directory · Investor access · Company funding database